Mirae Asset Global Investments
VRTX icon

Mirae Asset Global Investments’s Vertex Pharmaceuticals VRTX Stock Holding History

Mirae Asset Global Investments’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$104M Buy
210,209
+22,145
+12% +$9.81M 0.15% 90
2026
Q1 		$84M Buy
188,064
+13,717
+8% +$6.4M 0.03% 71
2025
Q4 		$79M Buy
174,347
+23,291
+15% +$10M 0.22% 83
2025
Q3 		$59.2M Buy
151,056
+6,468
+4% +$2.7M 0.19% 93
2025
Q2 		$64.4M Buy
144,588
+1,270
+0.9% +$585K 0.22% 86
2025
Q1 		$69.5M Buy
143,318
+23,769
+20% +$11.1M 0.28% 71
2024
Q4 		$48.4M Buy
119,549
+17,264
+17% +$8M 0.2% 94
2024
Q3 		$47.3M Buy
102,285
+10,016
+11% +$4.81M 0.21% 89
2024
Q2 		$43.6M Sell
92,269
-208,587
-69% -$90.5M 0.22% 81
2024
Q1 		$105M Buy
300,856
+4,178
+1% +$1.77M 0.23% 83
2023
Q4 		$121M Sell
296,678
-21,922
-7% -$8.1M 0.25% 82
2023
Q3 		$111M Buy
318,600
+41,032
+15% +$14.4M 0.24% 81
2023
Q2 		$97.7M Sell
277,568
-7,331
-3% -$2.47M 0.21% 92
2023
Q1 		$89.8M Sell
284,899
-20,923
-7% -$6.28M 0.21% 93
2022
Q4 		$88.3M Sell
305,822
-14,145
-4% -$4.31M 0.23% 94
2022
Q3 		$92.7M Sell
319,967
-15,755
-5% -$4.53M 0.25% 74
2022
Q2 		$94.6M Buy
335,722
+11,222
+3% +$3M 0.24% 76
2022
Q1 		$84.7M Buy
324,500
+39,313
+14% +$9.33M 0.18% 123
2021
Q4 		$62.7M Buy
285,187
+37,357
+15% +$7.26M 0.13% 170
2021
Q3 		$45M Buy
247,830
+78,091
+46% +$15.2M 0.11% 226
2021
Q2 		$34.2M Sell
169,739
-161,348
-49% -$33.7M 0.1% 262
2021
Q1 		$71.1M Sell
331,087
-179,437
-35% -$39.4M 0.25% 88
2020
Q4 		$121M Buy
510,524
+312,239
+157% +$71.6M 0.45% 39
2020
Q3 		$53.5M Buy
198,285
+23,102
+13% +$6.37M 0.27% 77
2020
Q2 		$50.9M Sell
175,183
-89,068
-34% -$24.1M 0.31% 58
2020
Q1 		$62.9M Buy
264,251
+177,194
+204% +$40.6M 0.49% 37
2019
Q4 		$19.1M Buy
87,057
+22,228
+34% +$4.5M 0.12% 209
2019
Q3 		$11M Buy
64,829
+7,812
+14% +$1.38M 0.08% 287
2019
Q2 		$10.4M Buy
57,017
+309
+0.5% +$54K 0.07% 291
2019
Q1 		$10.4M Buy
56,708
+2,805
+5% +$518K 0.08% 247
2018
Q4 		$8.93M Buy
53,903
+6,203
+13% +$1.07M 0.08% 263
2018
Q3 		$9.14M Buy
47,700
+12,772
+37% +$2.27M 0.07% 291
2018
Q2 		$5.61M Buy
34,928
+2,678
+8% +$415K 0.08% 163
2018
Q1 		$5.26M Buy
32,250
+2,960
+10% +$483K 0.07% 178
2017
Q4 		$4.39M Sell
29,290
-1,518
-5% -$225K 0.06% 200
2017
Q3 		$4.66M Buy
30,808
+10,071
+49% +$1.52M 0.08% 176
2017
Q2 		$2.66M Buy
20,737
+1,861
+10% +$224K 0.05% 259
2017
Q1 		$2.06M Buy
18,876
+13,953
+283% +$1.23M 0.04% 275
2016
Q4 		$363K Sell
4,923
-4,759
-49% -$387K 0.01% 436
2016
Q3 		$844K Sell
9,682
-607
-6% -$57.4K 0.02% 372
2016
Q2 		$885K Sell
10,289
-110
-1% -$9.51K 0.02% 330
2016
Q1 		$827K Sell
10,399
-11,806
-53% -$1.07M 0.02% 351
2015
Q4 		$2.79M Buy
22,205
+15,764
+245% +$1.9M 0.09% 180
2015
Q3 		$670K Sell
6,441
-350
-5% -$45K 0.03% 331
2015
Q2 		$838K Buy
6,791
+220
+3% +$27.7K 0.03% 330
2015
Q1 		$775K Buy
6,571
+1,187
+22% +$142K 0.03% 338
2014
Q4 		$639K Buy
5,384
+12
+0.2% +$1.35K 0.02% 322
2014
Q3 		$604K Buy
+5,372
New +$511K 0.02% 336
2013
Q3 		– Sell
-6,715
Closed -$538K – 445
2013
Q2 		$538K Buy
+6,715
New +$495K 0.03% 337

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Mirae Asset Global Investments's VRTX Position: Q2 2026 in Review

Mirae Asset Global Investments increased its Vertex Pharmaceuticals (VRTX) stake by 12% in Q2 2026, buying an estimated $9.81M and bringing the position to 210,209 shares worth $104M. The position accounts for 0.15% of the portfolio, ranked #90.

Mirae Asset Global Investments first reported a position in VRTX in Q2 2013 and has held it in 49 quarters since. The position peaked at $121M in Q4 2023. 484 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Mirae Asset Global Investments held 210,209 shares of Vertex Pharmaceuticals worth $104M as of Q2 2026.
  • Mirae Asset Global Investments bought 22,145 Vertex Pharmaceuticals shares in Q2 2026, an estimated $9.81M.
  • Vertex Pharmaceuticals made up 0.15% of Mirae Asset Global Investments's portfolio in Q2 2026, its #90 holding.
  • Mirae Asset Global Investments first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 49 quarters since.
  • Mirae Asset Global Investments's Vertex Pharmaceuticals position peaked at $121M in Q4 2023.
  • 484 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.